These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

276 related items for PubMed ID: 15780548

  • 1. Knowledge of and interest in hepatitis C treatment at a methadone clinic.
    Walley AY, White MC, Kushel MB, Song YS, Tulsky JP.
    J Subst Abuse Treat; 2005 Mar; 28(2):181-7. PubMed ID: 15780548
    [Abstract] [Full Text] [Related]

  • 2. Hazardous alcohol consumption and other barriers to antiviral treatment among hepatitis C positive people receiving opioid maintenance treatment.
    Watson B, Conigrave KM, Wallace C, Whitfield JB, Wurst F, Haber PS.
    Drug Alcohol Rev; 2007 May; 26(3):231-9. PubMed ID: 17454012
    [Abstract] [Full Text] [Related]

  • 3. Prevalence of hepatitis B and C infection in a methadone clinic population: implications for hepatitis B vaccination.
    Carter H, Robinson G, Hanlon C, Hailwood C, Massarotto A.
    N Z Med J; 2001 Jul 27; 114(1136):324-6. PubMed ID: 11548096
    [Abstract] [Full Text] [Related]

  • 4. Knowledge about Hepatitis-C among methadone maintenance treatment patients in Israel.
    Cohen-Moreno R, Schiff M, Levitt S, Bar-Hamburger R, Strauss S, Neumark Y.
    Subst Use Misuse; 2010 Jul 27; 45(1-2):58-76. PubMed ID: 20025439
    [Abstract] [Full Text] [Related]

  • 5. Knowledge and attitudes about treatment for hepatitis C virus infection and barriers to treatment among current injection drug users in Australia.
    Doab A, Treloar C, Dore GJ.
    Clin Infect Dis; 2005 Apr 15; 40 Suppl 5():S313-20. PubMed ID: 15768340
    [Abstract] [Full Text] [Related]

  • 6. Prescription opioid abuse among enrollees into methadone maintenance treatment.
    Rosenblum A, Parrino M, Schnoll SH, Fong C, Maxwell C, Cleland CM, Magura S, Haddox JD.
    Drug Alcohol Depend; 2007 Sep 06; 90(1):64-71. PubMed ID: 17386981
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Hepatitis C virus infection and injection drug users: prevention, risk factors, and treatment.
    Backmund M, Reimer J, Meyer K, Gerlach JT, Zachoval R.
    Clin Infect Dis; 2005 Apr 15; 40 Suppl 5():S330-5. PubMed ID: 15768343
    [Abstract] [Full Text] [Related]

  • 9. Management of hepatitis C among drug users attending general practice in Ireland: baseline data from the Dublin area hepatitis C in general practice initiative.
    Cullen W, Stanley J, Langton D, Kelly Y, Bury G.
    Eur J Gen Pract; 2007 Apr 15; 13(1):5-12. PubMed ID: 17366287
    [Abstract] [Full Text] [Related]

  • 10. Methadone maintenance treatment (MMT) in general practice or in specialized centers: profile of patients in the Swiss Canton of Vaud.
    Pelet A, Doll S, Huissoud T, Resplendino J, Besson J, Favrat B.
    Am J Drug Alcohol Abuse; 2007 Apr 15; 33(5):665-74. PubMed ID: 17891659
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Using latent class analysis to identify patterns of hepatitis C service provision in drug-free treatment programs in the U.S.
    Strauss SM, Rindskopf DM, Astone-Twerell JM, Des Jarlais DC, Hagan H.
    Drug Alcohol Depend; 2006 Jun 09; 83(1):15-24. PubMed ID: 16289523
    [Abstract] [Full Text] [Related]

  • 14. Hepatitis C virus prevalence and outcomes among injecting drug users on opioid replacement therapy.
    Hallinan R, Byrne A, Amin J, Dore GJ.
    J Gastroenterol Hepatol; 2005 Jul 09; 20(7):1082-6. PubMed ID: 15955218
    [Abstract] [Full Text] [Related]

  • 15. Physical and mental health in severe opioid-dependent patients within a randomized controlled maintenance treatment trial.
    Reimer J, Verthein U, Karow A, Schäfer I, Naber D, Haasen C.
    Addiction; 2011 Sep 09; 106(9):1647-55. PubMed ID: 21489005
    [Abstract] [Full Text] [Related]

  • 16. Integrating multiple programme and policy approaches to hepatitis C prevention and care for injection drug users: a comprehensive approach.
    Birkhead GS, Klein SJ, Candelas AR, O'Connell DA, Rothman JR, Feldman IS, Tsui DS, Cotroneo RA, Flanigan CA.
    Int J Drug Policy; 2007 Oct 09; 18(5):417-25. PubMed ID: 17854731
    [Abstract] [Full Text] [Related]

  • 17. Integrating services for injection drug users infected with hepatitis C virus with methadone maintenance treatment: challenges and opportunities.
    Litwin AH, Soloway I, Gourevitch MN.
    Clin Infect Dis; 2005 Apr 15; 40 Suppl 5():S339-45. PubMed ID: 15768345
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Injecting drug users' understanding of hepatitis C.
    O'Brien S, Day C, Black E, Dolan K.
    Addict Behav; 2008 Dec 15; 33(12):1602-5. PubMed ID: 18762384
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.